CAS: 1202896-51-2
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Brivaracetam-d7 REF: 4Z-B-105064CAS: 1202896-51-2 | - - - | To inquire | Mon 10 Mar 25 |
 | Brivaracetam-d7 REF: TR-B677647CAS: 1202896-51-2 | - - - | 520.00 €~3,571.00 € | Tue 11 Mar 25 |
 | Brivaracetam-d7 REF: 3D-IB181069CAS: 1202896-51-2 | Min. 95% | 769.00 €~4,049.00 € | Mon 14 Apr 25 |
Ref: 4Z-B-105064
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Monday 10 Mar 2025
Brivaracetam-d7
Controlled ProductCAS:1202896-51-2
Applications Brivaracetam-d7, is the labeled analogue of Brivaracetam (B677645), which is a 4-n-propyl analog of …
Formula:
C11H13D7N2O2
Color and Shape:
Off White Solid
Molecular weight:
219.33
Ref: TR-B677647
| 1mg | 964.00 € | ||
| 5mg | 3,571.00 € | ||
| 500µg | 520.00 € |
Estimated delivery in United States, on Tuesday 11 Mar 2025
Brivaracetam-d7
Controlled ProductCAS:1202896-51-2
Brivaracetam-d7 is a drug product that is used for analytical purposes. It is a synthetic, …
Formula:
C11H20N2O2
Purity:
Min. 95%
Molecular weight:
219.33 g/mol
Ref: 3D-IB181069
| 1mg | 1,157.00 € | ||
| 2mg | 1,880.00 € | ||
| 5mg | 4,049.00 € | ||
| 500µg | 769.00 € |
Estimated delivery in United States, on Monday 14 Apr 2025
